Mode
Text Size
Log in / Sign up

Narrowband UVB remains first-line phototherapy for vitiligo, with JAK inhibitors emerging as adjunctsNew light therapies and skin grafts offer hope for vitiligo patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider NB-UVB as first-line phototherapy for vitiligo; JAK inhibitor combinations are emerging but not yet standard.

This narrative review summarizes the role of phototherapy in vitiligo management, covering narrowband ultraviolet B (NB-UVB), excimer-based phototherapy, and ultraviolet radiation (UVR). The authors discuss combination strategies incorporating JAK inhibitors, platelet-rich plasma, or cellular grafting techniques. NB-UVB is presented as the first-line phototherapy option based on long-standing clinical experience.

Excimer lasers offer targeted treatment for localized lesions. Emerging evidence suggests that combining phototherapy with JAK inhibitors may enhance repigmentation, though data remain preliminary. Platelet-rich plasma and cellular grafting are also explored as adjuncts, but their efficacy is not firmly established.

The review is narrative and does not report pooled effect sizes, sample sizes, or comparative outcomes. No safety data or limitations are explicitly noted. The authors do not provide a certainty assessment or practice recommendations.

Clinicians should interpret these findings as a qualitative overview rather than a quantitative synthesis. While NB-UVB remains a standard approach, the role of newer combinations awaits confirmation from controlled trials.

Vitiligo causes patches of skin to lose their color. This condition can be deeply distressing for those who live with it. A recent narrative review looks at the various ways doctors try to treat this skin disorder. The article examines several approaches that have shown promise in helping people regain pigment in their skin.

The review discusses specific light therapies. Narrowband ultraviolet B light and excimer-based phototherapy are two methods that use ultraviolet radiation to target the affected areas. The text also mentions combination strategies. These might include using JAK inhibitors alongside light therapy. Other options mentioned include platelet-rich plasma and cellular grafting techniques. These advanced methods aim to repair the skin and bring color back.

The review does not report specific patient numbers or exact results from a single trial. Instead, it gathers information from existing reports to give a broad picture of what is available. No safety signals or adverse events were detailed in this specific summary of the literature. Because the input did not provide data on side effects or discontinuations, the narrative focuses on the types of interventions available. This review serves as a guide to the landscape of current treatments for vitiligo.

What this means for you:
Light therapies and cellular grafting are options for treating vitiligo skin loss.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Vitiligo is a chronic autoimmune disorder characterized by selective melanocyte loss and progressive depigmentation. Narrowband ultraviolet B (NB-UVB) and excimer-based phototherapy are widely regarded as standard treatments in clinical practice and remain the most effective approaches for inducing repigmentation. However, excessive or uncontrolled ultraviolet radiation (UVR) exposure can impair skin barrier function, cause melanocyte dysfunction, and increase the risk of photoaging and carcinogenesis. This apparent paradox arises from the bidirectional biological effects of UVR: on the one hand, UVR activates melanocytes and promotes skin pigmentation through coordinated effects on melanocyte maturation, proliferation, and melanin synthesis, while on the other hand, UVR can induce oxidative stress, DNA damage, apoptosis, and genomic instability. Therefore, combination strategies incorporating JAK inhibitors, platelet-rich plasma, or cellular grafting techniques have been increasingly explored in clinical practice. In this review, we provide an integrated perspective on the dual effects of UVR on melanocyte biology, discuss emerging combination therapies for vitiligo, and highlight the mechanistic links between phototherapy, melanocyte homeostasis, and melanoma risk.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.